---
document_datetime: 2024-09-23 15:05:14
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/repaglinide-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: repaglinide-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.5506896
conversion_datetime: 2025-12-18 10:40:51.504211
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Repaglinide Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                      | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0017              | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size | 18/03/2022                          | n/a                                         |                                  |           |
| IA/0016              | A.7 - Administrative change - Deletion of manufacturing sites                                                                                              | 21/01/2022                          | 24/04/2023                                  | Annex II and PL                  |           |

1 Notifications  are issued for  type I variations  and Article  61(3) notifications  (unless part of a group including a type II variation  or extension  application  or a worksharing  application).  Opinions are  issued for all  other procedures.

2 A Commission  decision  (CD) is issued for procedures  that affect  the terms of the marketing  authorisation  (e.g.  summary of  product characteristics,  annex  II, labelling,  package  leaflet).  The CD is issued within two  months of  the opinion  for variations  falling  under the scope of  Article  23.1a(a)  of Regulation  (EU) No.  712/2012, or within  one year  for other procedures.

3

SmPC  (Summary  of Product Characteristics),  Annex  II, Labelling,  PL (Package  Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0015     | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 15/03/2021   | n/a        |                 |                             |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-----------------------------|
| IAIN/0014/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer | 21/08/2020   | 01/09/2021 | Annex II and PL | responsible for importation |
| IA/0013     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 11/05/2020   | n/a        |                 |                             |
| II/0009/G   | This was an application for a group of variations. B.II.a.3.b.1 - Changes in the composition (excipients) of the finished product - Other excipients                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 12/12/2019   | n/a        |                 |                             |

<div style=\"page-break-after: always\"></div>

| - Any minor adjustment composition of the finished excipients B.II.b.1.a - Replacement manufacturing site for site B.II.b.1.b - Replacement manufacturing site for site B.II.b.1.e - Replacement manufacturing site for manufacturing operation(s) release, batch control, packaging, for non-sterile B.II.b.3.z - Change in the the finished or intermediate B.II.b.5.z - Change to applied during the manufacture product - Other variation B.II.d.1.e - Change in and/or limits of the finished outside the approved specifications B.II.d.1.g - Change in and/or limits of the finished replacement (excluding product) of a specification corresponding test method quality issue B.II.b.3.z - Change in the   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| IAIN/0012/G   | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging      | 03/12/2019   | n/a        |                        |
|---------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| IA/0011       | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                            | 11/07/2019   | n/a        |                        |
| IA/0010       | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                             | 05/03/2019   | n/a        |                        |
| T/0008        | Transfer of Marketing Authorisation                                                                                                                                                                                                                    | 01/02/2019   | 25/02/2019 | SmPC, Labelling and PL |
| IAIN/0007/G   | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site | 04/10/2018   | 25/02/2019 | Annex II and PL        |

<div style=\"page-break-after: always\"></div>

|             | and quality control testing of the FP - or addition of a manufacturer for importation and/or batch release - including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |            |                                  | arrangements Replacement responsible Not   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------|
| IA/0006     | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 16/12/2016 | n/a        |                                  |                                            |
| R/0005      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 21/07/2016 | 19/09/2016 | SmPC, Annex II, Labelling and PL |                                            |
| IAIN/0004/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes | 15/09/2015 | 19/09/2016 | SmPC, Labelling and PL           |                                            |
| IAIN/0003   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV and/or changes in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 30/08/2013 | n/a        |                                  | (including contact details)                |

<div style=\"page-break-after: always\"></div>

|         | PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |                                  |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| IB/0002 | Update section 4.5 of SmPC in order to include a new drug-drug interaction with deferasirox after CHMP adoption of safety variation on 15 March 2012 to the Marketing Authorisations of Novonorm and Prandin (EMEA/H/C/XXXX/WS/223). Section 2 of the Package leaflet is updated in accordance. PI was also updated according to the latest QRD template. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 26/07/2012 | 19/09/2016 | SmPC, Annex II, Labelling and PL |